Implementing innovations in the pharmaceutical market is an ambitious task. In an industry that requires precise and reproducible results, changes to current systems always involve certain challenges. According to Dr Marcus Knöll of Bosch, an external study can provide certainty, which was the case with the uniquely shaped ‘Gentlewing’ mixing device from Hüttlin GmbH, a subsidiary of Bosch Packaging Technology, based in Schopfheim, Germany. A study conducted by the University of Mainz, Germany, confirmed that the special design of the device offers several advantages to users – while achieving the same processing results as a conventional mixer.
https://international-pharma.com/wp-content/uploads/2014/10/Gentlewing.pdf